SAB Biotherapeutics Inc (NAS:SABS)
$ 3.77 -0.16 (-4.07%) Market Cap: 288.27 Mil Enterprise Value: 187.05 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 30/100

SAB Biotherapeutics Inc Annual Shareholders Meeting Transcript

Jun 18, 2026 / 02:00 PM GMT
Release Date Price: $4 (+3.63%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SABS.OQ - SAB Biotherapeutics Inc
SAB Biotherapeutics Inc Annual Shareholders Meeting
Jun 18, 2026 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by, and welcome to the SAB Biotherapeutics meeting. I will now turn the call over to Samuel J. Reich.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning, and welcome to the 2026 Annual Meeting of Stockholders of SAB Biotherapeutics, Inc.

We are holding this year's annual meeting as an entirely virtual meeting.

Stockholders who require technical assistance during the meeting can call Brodridge's technical support line at the phone number posted on the meeting login page.

I am Sam Reich, Chief Executive
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot